{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:35:58Z","timestamp":1787888158309,"version":"build-2784847793"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/sla.0b013e318155a7b6","type":"journal-article","created":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T07:05:30Z","timestamp":1190185530000},"page":"559-567","source":"Crossref","is-referenced-by-count":196,"title":["Survival After Radiofrequency Ablation of Colorectal Liver Metastases"],"prefix":"10.1097","volume":"246","author":[{"given":"Allan E.","family":"Siperstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eren","family":"Berber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Ballem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikesh T.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/bjs.5581","article-title":"Current role of radiofrequency ablation for the treatment of colorectal liver metastases.","volume":"93","author":"McKay","year":"2006","journal-title":"Br J Surg"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF02725339","article-title":"Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.","volume":"7","author":"Wood","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ctrv.2005.12.011","article-title":"Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties.","volume":"32","author":"Biasco","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"R6-7-20210203","first-page":"1","article-title":"Factors influencing survival in patients with untreated hepatic metastases.","volume":"127","author":"Jaffe","year":"1968","journal-title":"Surg Gynecol Obstet"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO;2-J","article-title":"The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.","volume":"23","author":"Bengmark","year":"1969","journal-title":"Cancer"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","article-title":"A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.","volume":"206","author":"Chang","year":"1987","journal-title":"Ann Surg"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(98)02309-5","article-title":"Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.","volume":"352","author":"Cunningham","year":"1998","journal-title":"Lancet"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.","volume":"22","author":"Goldberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s004640000067","article-title":"Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations.","volume":"14","author":"Siperstein","year":"2000","journal-title":"Surg Endosc"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2005.12.039","article-title":"Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study.","volume":"23","author":"Berber","year":"2005","journal-title":"J Clin Oncol"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.00.349","article-title":"Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma.","volume":"23","author":"Leonard","year":"2005","journal-title":"J Clin Oncol"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jso.10114","article-title":"The TNM system: our language for cancer care.","volume":"80","author":"Greene","year":"2002","journal-title":"J Surg Oncol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0b013e318155a7b6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:01:35Z","timestamp":1620975695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000658-200710000-00007"}},"subtitle":["10-Year Experience"],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e318155a7b6","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}